Atalanta Therapeutics
Developing neurodegenerative disease treatments using proprietary RNA interference platform.
Developing neurodegenerative disease treatments using proprietary RNA interference platform.
Sector
Life SciencesCategory
TherapeuticsLocation
Boston, MAInitial Investment
2019Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing its proprietary RNA interference platform.
